
A technique called vascular-targeted photodynamic therapy (VTP) has been developed that sent 49% of patients suffering from prostate cancer into …
Pharma sees climate disruption as growing supply-chain risk
Manchester NHS-MHRA partnership to test new technologies in real-world care

